Christos Lymberopoulos

Title: Innovations in Pharmaceutical Aerosols: The Contributions of Christos Lymberopoulos

Introduction

Christos Lymberopoulos is an accomplished inventor based in Rancho Cucamonga, CA (US). He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of inhalation therapies. His innovative work focuses on improving the delivery and efficacy of medications for respiratory conditions.

Latest Patents

Lymberopoulos holds a patent for a "Stable epinephrine suspension formulation for inhalation with HFO propellant." This patent describes pharmaceutical aerosol formulations that contain pre-micronized epinephrine, co-solvent ethanol, surfactant polysorbate 80, and the propellant trans-1,3,3,3-tetrafluoropropene (HFO-1234ze(E)). The formulations are designed for use in a pressurized metered dose inhaler, providing a highly efficient delivery of pre-micronized epinephrine particles into patients' respiratory tracts. The advantages of this formulation include high efficacy, improved safety, and a low global warming potential (GWP), making it environmentally friendly.

Career Highlights

Lymberopoulos is currently associated with Amphastar Pharmaceuticals, Inc., where he continues to innovate in the field of pharmaceutical aerosols. His work has contributed to advancements in inhalation therapies, enhancing patient outcomes and safety.

Collaborations

Throughout his career, Lymberopoulos has collaborated with notable colleagues, including Jack Yongfeng Zhang and Mary Zi-Ping Luo. These collaborations have fostered a productive environment for innovation and development in pharmaceutical formulations.

Conclusion

Christos Lymberopoulos exemplifies the spirit of innovation in the pharmaceutical industry. His contributions to inhalation therapies through his patented formulations demonstrate a commitment to improving patient care and environmental sustainability.